This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rob Holgate, PhD
Senior Director, Protein Engineering and Discovery at Abzena

Profile

Rob has over 20 years experience in Drug Discovery and early stage Development. After obtaining his PhD in Molecular Medicine at UCL, he moved to The University of York as a post-doctoral researcher. He subsequently worked at Cambridge Antibody Technology (now part of AZ) where he was a Senior Scientist within Antibody Engineering then Team Leader of the High Throughput Expression team. Rob joined Antitope (now Abzena) in 2008 as a Research Manager and now leads Abzena’s Discovery and Protein Engineering group overseeing Abzena’s antibody discovery, antibody humanization, protein deimmunisation and bespoke engineering projects.

Agenda Sessions

  • Addressing the Challenges of Therapeutic Antibody Development through the Application of Design and Developability

    8:45am
  • Addressing the Challenges of Therapeutic Antibody Development through the Application of Design and Developability

    On Demand